Information PortalData PortalKnowledge Portal

Data Matrix

Tools & Workflows

Documentation

Psoriasis (Disease Or Phenotype)

Omim:MTHU036411

Nci:C3346

Msh:D011565

Mondo:MONDO:5083

Medcin:MEDCIN:33107

Mdr:MDR:10037153

Id:dde81f7b-fd33-5713-83d4-27e873bd34c9

Icpc2icd10eng:MTHU062353

Icd10cm:L40

Efo:EFO:676

Doid:DOID:8893

Chv:CHV:10310

Results found

Linked to

	Label	Description
	Hydrocortisone indication Psoriasis Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Dexamethasone indication Psoriasis Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Methotrexate indication Psoriasis Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	betamethasone indication Psoriasis Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Fumaric Acid indication Psoriasis Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	tazarotene indication Psoriasis Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Hydrocortisone hemisuccinate indication Psoriasis Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Triamcinolone diacetate indication Psoriasis Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Ammonia indication Psoriasis Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Acetic acid 2-((8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxo-ethyl ester indication Psoriasis Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Hydrocortisone indication Psoriasis

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Dexamethasone indication Psoriasis

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Methotrexate indication Psoriasis

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

betamethasone indication Psoriasis

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Fumaric Acid indication Psoriasis

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

tazarotene indication Psoriasis

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Hydrocortisone hemisuccinate indication Psoriasis

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Triamcinolone diacetate indication Psoriasis

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Ammonia indication Psoriasis

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Acetic acid 2-((8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxo-ethyl ester indication Psoriasis

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.